Nirmal K. Banda
Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum
Banda, Nirmal K.; Mehta, Gaurav; Chao, Ying; Wang, Guankui; Inturi, Swetha; Fossati-Jimack, Liliane; Botto, Marina; Wu, LinPing; Moghimi, Seyed Moein; Simberg, Dmitri
Authors
Gaurav Mehta
Ying Chao
Guankui Wang
Swetha Inturi
Liliane Fossati-Jimack
Marina Botto
LinPing Wu
Seyed Moein Moghimi
Dmitri Simberg
Abstract
Background The complement system is a key component of innate immunity implicated in the neutralization and clearance of invading pathogens. Dextran coated superparamagnetic iron oxide (SPIO) nanoparticle is a promising magnetic resonance imaging (MRI) contrast agent. However, dextran SPIO has been associated with significant number of complement-related side effects in patients and some agents have been discontinued from clinical use (e.g., Feridex™). In order to improve the safety of these materials, the mechanisms of complement activation by dextran-coated SPIO and the differences between mice and humans need to be fully understood. Methods 20 kDa dextran coated SPIO nanoworms (SPIO NW) were synthesized using Molday precipitation procedure. In vitro measurements of C3 deposition on SPIO NW using sera genetically deficient for various components of the classical pathway (CP), lectin pathway (LP) or alternative pathway (AP) components were used to study mechanisms of mouse complement activation. In vitro measurements of fluid phase markers of complement activation C4d and Bb and the terminal pathway marker SC5b-C9 in normal and genetically deficient sera were used to study the mechanisms of human complement activation. Mouse data were analyzed by non-paired t-test, human data were analyzed by ANOVA followed by multiple comparisons with Student-Newman-Keuls test. Results In mouse sera, SPIO NW triggered the complement activation via the LP, whereas the AP contributes via the amplification loop. No involvement of the CP was observed. In human sera the LP together with the direct enhancement of the AP turnover was responsible for the complement activation. In two samples out of six healthy donors there was also a binding of anti-dextran antibodies and C1q, suggesting activation via the CP, but that did not affect the total level of C3 deposition on the particles. Conclusions There were important differences and similarities in the complement activation by SPIO NW in mouse versus human sera. Understanding the mechanisms of immune recognition of nanoparticles in mouse and human systems has important preclinical and clinical implications and could help design more efficient and safe nano-formulations.
Citation
Banda, N. K., Mehta, G., Chao, Y., Wang, G., Inturi, S., Fossati-Jimack, L., …Simberg, D. (2014). Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum. Particle and Fibre Toxicology, 11, Article 64. https://doi.org/10.1186/s12989-014-0064-2
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 8, 2014 |
Online Publication Date | Nov 26, 2014 |
Publication Date | Nov 26, 2014 |
Deposit Date | Apr 21, 2016 |
Publicly Available Date | Oct 12, 2016 |
Journal | Particle and Fibre Toxicology |
Publisher | BioMed Central |
Peer Reviewed | Peer Reviewed |
Volume | 11 |
Article Number | 64 |
DOI | https://doi.org/10.1186/s12989-014-0064-2 |
Public URL | https://durham-repository.worktribe.com/output/1414124 |
Files
Published Journal Article
(1.3 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
© Banda et al.; licensee BioMed Central Ltd. 2014
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
You might also like
Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy
(2013)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search